Valenta Farmatsevtika OAO: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Valenta Farmatsevtika OAO Appoints Auditor for FY 2013-SKRIN
SKRIN reported that Valenta Farmatsevtika OAO has appointed AudiKons OOO as its auditor for the fiscal year 2013.
Latest Developments for Valenta Farmatsevtika OAO
Latest Key Developments in Pharmaceuticals
- Chembio Diagnostics Inc appoints president and CEO
- Theravance Inc and GlaxoSmithKline plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Theravance Inc and GlaxoSmithKline Plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Cipher Pharmaceuticals Inc announces Larry Andrews will be stepping down as President and Chief Executive Officer
- Share this
- Digg this